Clinical Trial Update: OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update showing results for onabotulinumtoxinA (Botox) in treating urinary incontinence in patients with overactive bladder; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2017-11-06